These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28075105)

  • 1. Heart Failure Due to Reduced Ejection Fraction: Medical Management.
    Chavey WE; Hogikyan RV; Van Harrison R; Nicklas JM
    Am Fam Physician; 2017 Jan; 95(1):13-20. PubMed ID: 28075105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of predictive modeling in implementing optimal heart failure therapy.
    Prasad H; Sra J; Levy WC; Stapleton DD
    Am J Med Sci; 2011 Mar; 341(3):185-90. PubMed ID: 21233695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
    Rogers FJ; Saghir Z
    J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
    Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction.
    Veenis JF; Brunner-La Rocca HP; Linssen GC; Geerlings PR; Van Gent MW; Aksoy I; Oosterom L; Moons AH; Hoes AW; Brugts JJ;
    Eur J Prev Cardiol; 2019 Sep; 26(13):1399-1407. PubMed ID: 30866680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.
    Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I
    Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy doses at hospital discharge in patients with existing and de novo heart failure.
    Diamant MJ; Virani SA; MacKenzie WJ; Ignaszewski A; Toma M; Hawkins NM
    ESC Heart Fail; 2019 Aug; 6(4):774-783. PubMed ID: 31218850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foundations of Pharmacotherapy for Heart Failure With Reduced Ejection Fraction: Evidence Meets Practice, Part II.
    McIlvennan CK; Page RL
    J Cardiovasc Nurs; 2016; 31(6):545-554. PubMed ID: 27028591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.
    Atwater BD; Dai D; Allen-Lapointe NM; Al-Khatib SM; Zimmer LO; Sanders GD; Peterson ED
    Am Heart J; 2012 Nov; 164(5):750-755.e1. PubMed ID: 23137506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
    Ahmed A
    J Am Coll Cardiol; 2003 May; 41(10):1851-2. PubMed ID: 12767683
    [No Abstract]   [Full Text] [Related]  

  • 16. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.
    Driscoll A; Currey J; Tonkin AM
    JAMA Cardiol; 2016 Oct; 1(7):842-843. PubMed ID: 27556747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
    Kiel RG; Deedwania P
    Expert Opin Drug Saf; 2015; 14(12):1855-63. PubMed ID: 26488593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    Ouwerkerk W; Zwinderman AH; Ng LL; Demissei B; Hillege HL; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Ter Maaten JM; Lang CC; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Voors AA
    J Am Coll Cardiol; 2018 Jan; 71(4):386-398. PubMed ID: 29389354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of heart failure in patients with reduced left- ventricular ejection fraction].
    Elskjær H
    Ugeskr Laeger; 2018 Oct; 180(20A):. PubMed ID: 30274585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.